Publications

Export 25 results:
Auteur Title Type [ Année(Asc)]
Filtres: Mot-clé is Schizophrenia  [Enlever les filtres]
2015
Baldwin CH, Srivastava LK.  2015.  Can the neurodevelopmental theory account for sex differences in schizophrenia across the life span? J Psychiatry Neurosci. 40(2):75-7.
Bhardwaj SK, Stojkovic K, Kiessling S, Srivastava LK, Cermakian N.  2015.  Constant light uncovers behavioral effects of a mutation in the schizophrenia risk gene Dtnbp1 in mice.. Behav Brain Res. 284:58-68.
Keshavan MS, Mehta UMeherwan, Padmanabhan JL, Shah JL.  2015.  Dysplasticity, metaplasticity, and schizophrenia: Implications for risk, illness, and novel interventions.. Dev Psychopathol. 27(2):615-35.
Wheeler AL, Wessa M, Szeszko PR, Foussias G, M Chakravarty M, Lerch JP, DeRosse P, Remington G, Mulsant BH, Linke J et al..  2015.  Further neuroimaging evidence for the deficit subtype of schizophrenia: a cortical connectomics analysis.. JAMA Psychiatry. 72(5):446-55.
Gerretsen P, Menon M, M Chakravarty M, Lerch JP, Mamo DC, Remington G, Pollock BG, Graff-Guerrero A.  2015.  Illness denial in schizophrenia spectrum disorders: a function of left hemisphere dominance.. Hum Brain Mapp. 36(1):213-25.
Girard SL, Dion PA, Bourassa CV, Geoffroy S, Lachance-Touchette P, Barhdadi A, Langlois M, Joober R, Krebs M-O, Dubé M-P et al..  2015.  Mutation burden of rare variants in schizophrenia candidate genes.. PLoS One. 10(6):e0128988.
Behdinan T, Foussias G, Wheeler AL, Stefanik L, Felsky D, Remington G, Rajji TK, M Chakravarty M, Voineskos AN.  2015.  Neuroimaging predictors of functional outcomes in schizophrenia at baseline and 6-month follow-up.. Schizophr Res. 169(1-3):69-75.
Shah JL, Tandon N, Howard ER, Mermon D, Miewald JM, Montrose DM, Keshavan MS.  2015.  Pituitary volume and clinical trajectory in young relatives at risk for schizophrenia.. Psychol Med. 45(13):2813-24.
Whitley R, Palmer V, Gunn J.  2015.  Recovery from severe mental illness.. CMAJ. 187(13):951-2.
Lepage M, Hawco C, Bodnar M.  2015.  Relational Memory as a Possible Neurocognitive Marker of Schizophrenia.. JAMA Psychiatry. 72(9):946-7.
Lal S, Malla A.  2015.  Service Engagement in First-Episode Psychosis: Current Issues and Future Directions.. Can J Psychiatry. 60(8):341-5.
M Chakravarty M, Rapoport JL, Giedd JN, Raznahan A, Shaw P, D Collins L, Lerch JP, Gogtay N.  2015.  Striatal shape abnormalities as novel neurodevelopmental endophenotypes in schizophrenia: a longitudinal study.. Hum Brain Mapp. 36(4):1458-69.
Haro JMaria, Altamura C, Corral R, Elkis H, Evans J, Malla A, Krebs M-O, Zink M, Bernasconi C, Lalonde J et al..  2015.  Understanding the impact of persistent symptoms in schizophrenia: Cross-sectional findings from the Pattern study.. Schizophr Res. 169(1-3):234-40.
2014
Roy L, Crocker AG, Nicholls TL, Latimer E, Ayllon AReyes.  2014.  Criminal behavior and victimization among homeless individuals with severe mental illness: a systematic review.. Psychiatr Serv. 65(6):739-50.
Wheeler AL, M Chakravarty M, Lerch JP, Pipitone J, Daskalakis ZJ, Rajji TK, Mulsant BH, Voineskos AN.  2014.  Disrupted prefrontal interhemispheric structural coupling in schizophrenia related to working memory performance.. Schizophr Bull. 40(4):914-24.
Plitman E, Nakajima S, de la Fuente-Sandoval C, Gerretsen P, M Chakravarty M, Kobylianskii J, Chung JKu, Caravaggio F, Iwata Y, Remington G et al..  2014.  Glutamate-mediated excitotoxicity in schizophrenia: a review.. Eur Neuropsychopharmacol. 24(10):1591-605.
Whitley R.  2014.  Introducing recovery.. Can J Psychiatry. 59(5):233-5.
Pidsley R, Viana J, Hannon E, Spiers H, Troakes C, Al-Saraj S, Mechawar N, Turecki G, Schalkwyk LC, Bray NJ et al..  2014.  Methylomic profiling of human brain tissue supports a neurodevelopmental origin for schizophrenia.. Genome Biol. 15(10):483.
Richard-Devantoy S, Orsat M, Dumais A, Turecki G, Jollant F.  2014.  Neurocognitive vulnerability: suicidal and homicidal behaviours in patients with schizophrenia.. Can J Psychiatry. 59(1):18-25.
Malla A.  2014.  The role of cognition in outcome in schizophrenia and related disorders.. Can J Psychiatry. 59(1):3-4.
Latimer E, Naidu A, Moodie EEM, Clark RE, Malla A, Tamblyn R, Wynant W.  2014.  Variation in long-term antipsychotic polypharmacy and high-dose prescribing across physicians and hospitals.. Psychiatr Serv. 65(10):1210-7.
2013
Keshavan MS, Shah JL.  2013.  Violence and mental illness.. Asian J Psychiatr. 6(1):1-2.